Answers are grounded in this paper and cite their sources.
IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide, with marked heterogeneity in its clinical course and kidney outcomes. This review examines the mechanisms of podocyte injury downstream of the “four hits,” organizing the evidence along a continuum from adaptive foot process effacement (FPE) to podocyte detachment and depletion. This process represents a transition from compensation to decompensation. FPE initially reflects active podocyte remodeling in response to injury and may resolve once the injurious stimulus is removed. When injury exceeds their compensatory capacity, however, podocytes begin to detach from the glomerular basement membrane, and their terminally differentiated state renders this loss irreversible. Nevertheless, no widely accepted criteria currently define the boundary between reversible and irreversible injury. We summarize the available evidence on biomarkers of podocyte injury in IgAN to assess their potential for monitoring this process. This understanding is consistent with current approaches to individualized IgAN treatment: combining established immunosuppressive and supportive therapies with targeted interventions at different stages of injury to advance individualized treatment strategies.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: